Heritable GATA2 mutations associated with familial AML-MDS: A case report and review of literature

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Gao, Juehua ^a   Gentzler, Ryan D ^a   Timms, Andrew E ^b,c   Horwitz, Marshall S ^b   Frankfurt, Olga ^a   Altman, Jessica K ^a   Peterson, Loann C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Familial acute myeloid leukemia myelodysplastic syndrome; GATA2

Indexed keywords

CD33 ANTIGEN; CD7 ANTIGEN; HEMOGLOBIN; HYPERTENSIVE FACTOR; LEUCINE; LYSINE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; THREONINE; TRANSCRIPTION FACTOR GATA 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTIFICIAL VENTILATION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COUGHING; DISEASE DURATION; FAMILY HISTORY; FEMALE; FEVER; FLOW CYTOMETRY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HETEROZYGOTE; HUMAN; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; LYMPHEDEMA; MISSENSE MUTATION; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; NORMOCHROMIC NORMOCYTIC ANEMIA; PNEUMONIA; REDUCED INTENSITY CONDITIONING; REVIEW; THROMBOCYTOPENIA;

ACUTE DISEASE; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GATA2 TRANSCRIPTION FACTOR; HETEROZYGOTE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MIDDLE AGED; MUTATION, MISSENSE; MYELODYSPLASTIC SYNDROMES;

EID: 84899934011     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-7-36     Document Type: Review

References (27)

1. Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay. Murphy KM, Levis M, Hafez MJ, Geiger T, Cooper LC, Smith BD, Small D, Berg KD, J Mol Diagn 2003 5 96 102 10.1016/S1525-1578(10)60458-8 12707374
2. Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations. Gorello P, Cazzaniga G, Alberti F, Dell'Oro MG, Gottardi E, Specchia G, Roti G, Rosati R, Martelli MF, Diverio D, Lo Coco F, Biondi A, Saglio G, Mecucci C, Falini B, Leukemia 2006 20 1103 1108 10.1038/sj.leu.2404149 16541144
3. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N, Shigesada K, Ito Y, Benson KF, Raskind WH, Rossier C, Antonarakis SE, Israels S, McNicol A, Weiss H, Horwitz M, Scott HS, Blood 2002 99 1364 1372 10.1182/blood.V99.4.1364 11830488
4. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Tsai FY, Orkin SH, Blood 1997 89 3636 3643 9160668
5. Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2. Kitajima K, Tanaka M, Zheng J, Yen H, Sato A, Sugiyama D, Umehara H, Sakai E, Nakano T, Blood 2006 107 1857 1863 10.1182/blood-2005-06-2527 16254139
6. High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Luesink M, Hollink IH, van der Velden VH, Knops RH, Boezeman JB, de Haas V, Trka J, Baruchel A, Reinhardt D, van der Reijden BA, van den Heuvel-Eibrink MM, Zwaan CM, Jansen JH, Blood 2012 120 2064 2075 10.1182/blood-2011-12-397083 22786876
7. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, Dohner H, Pollack JR, N Engl J Med 2004 350 1605 1616 10.1056/NEJMoa031046 15084693
8. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Fasan A, Eder C, Haferlach C, Grossmann V, Kohlmann A, Dicker F, Kern W, Haferlach T, Schnittger S, Leukemia 2013 27 482 485 10.1038/leu.2012.174 22814295
9. CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76.8% of cases with TET2 and GATA2 alterations impacting prognosis. Grossmann V, Haferlach C, Nadarajah N, Fasan A, Weissmann S, Roller A, Eder C, Stopp E, Kern W, Haferlach T, Kohlmann A, Schnittger S, Br J Haematol 2013 161 649 658 10.1111/bjh.12297 23521373
10. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, Kok CH, Gagliardi L, Friend KL, Ekert PG, Butcher CM, Brown AL, Lewis ID, To LB, Timms AE, Storek J, Moore S, Altree M, Escher R, Bardy PG, Suthers GK, D'Andrea RJ, Horwitz MS, Scott HS, Nat Genet 2011 43 1012 1017 10.1038/ng.913 21892162
11. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, Spalding C, Hughes S, Pittaluga S, Raffeld M, Sorbara LR, Elloumi HZ, Kuhns DB, Turner ML, Cowen EW, Fink D, Long-Priel D, Hsu AP, Ding L, Paulson ML, Whitney AR, Sampaio EP, Frucht DM, DeLeo FR, Holland SM, Blood 2010 115 1519 1529 10.1182/blood-2009-03-208629 20040766
12. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM, Blood 2011 118 2653 2655 10.1182/blood-2011-05-356352 21670465
13. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, Jardine L, Pagan S, Dimmick I, Chua I, Wallis J, Lordan J, Morgan C, Kumararatne DS, Doffinger R, van der Burg M, van Dongen J, Cant A, Dick JE, Hambleton S, Collin M, J Exp Med 2011 208 227 234 10.1084/jem.20101459 21242295
14. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, Murday VA, Hodgson S, Keenan R, Pilz DT, Martinez-Corral I, Makinen T, Mortimer PS, Jeffery S, Trembath RC, Mansour S, Nat Genet 2011 43 929 931 10.1038/ng.923 21892158
15. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Mansour S, Connell F, Steward C, Ostergaard P, Brice G, Smithson S, Lunt P, Jeffery S, Dokal I, Vulliamy T, Gibson B, Hodgson S, Cottrell S, Kiely L, Tinworth L, Kalidas K, Mufti G, Cornish J, Keenan R, Mortimer P, Murday V, Lymphoedema Research Consortium, Am J Med Genet A 2010 152A 2287 2296 10.1002/ajmg.a.33445 20803646
16. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Bodor C, Renneville A, Smith M, Charazac A, Iqbal S, Etancelin P, Cavenagh J, Barnett MJ, Kramarzova K, Krishnan B, Matolcsy A, Preudhomme C, Fitzgibbon J, Owen C, Haematologica 2012 97 890 894 10.3324/haematol.2011.054361 22271902
17. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia. Holme H, Hossain U, Kirwan M, Walne A, Vulliamy T, Dokal I, Br J Haematol 2012 158 242 248 10.1111/j.1365-2141.2012.09136.x 22533337
18. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Pasquet M, Bellanne-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O, Petit A, Rohrlich P, Ferrand C, van den N, Poirel HA, Lamy T, Ouachee-Chardin M, Mansat-De Mas V, Corre J, Recher C, Plat G, Bachelerie F, Donadieu J, Delabesse E, Blood 2013 121 822 829 10.1182/blood-2012-08-447367 23223431
19. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J, Hsu AP, Dyack S, Fernandez CV, Chong CE, Babic M, Bardy PG, Shimamura A, Zhang MY, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott HS, Harvey NL, Blood 2012 119 1283 1291 10.1182/blood-2011-08-374363 22147895
20. GATA2 mutations lead to MDS and AML. Hyde RK, Liu PP, Nat Genet 2011 43 926 927 10.1038/ng.949 21956389
21. Recognizing familial myeloid leukemia in adults. Nickels EM, Soodalter J, Churpek JE, Godley LA, Ther Adv Hematol 2013 4 254 269 10.1177/2040620713487399 23926458
22. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Zhang SJ, Ma LY, Huang QH, Li G, Gu BW, Gao XD, Shi JY, Wang YY, Gao L, Cai X, Ren RB, Zhu J, Chen Z, Chen SJ, Proc Natl Acad Sci U S A 2008 105 2076 2081 10.1073/pnas.0711824105 18250304
23. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. West RR, Hsu AP, Holland SM, Cuellar-Rodriguez J, Hickstein DD, Haematologica 2014 99 2 276 81 doi: 10.3324/haematol.2013.090217. Epub 2013 Sep 27 10.3324/haematol.2013.090217 24077845
24. Familial partial monosomy 7 and myelodysplasia: different parental origin of the monosomy 7 suggests action of a mutator gene. Minelli A, Maserati E, Giudici G, Tosi S, Olivieri C, Bonvini L, de Filippi P, Biondi A, Lo Curto f, Pasquali F, Danesino C, Cancer Genet Cytogenet 2001 124 147 151 10.1016/S0165-4608(00)00344-7 11172908
25. Familial acute myeloid leukemia with monosomy 7: late onset and involvement of a multipotential progenitor cell. Kwong YL, Ng MH, Ma SK, Cancer Genet Cytogenet 2000 116 170 173 10.1016/S0165-4608(99)00121-1 10640152
26. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, Hsu AP, Zerbe CS, Calvo KR, Wilder J, Kurlander R, Olivier KN, Holland SM, Hickstein DD, Blood 2011 118 3715 3720 10.1182/blood-2011-06-365049 21816832
27. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. Goldin LR, Kristinsson SY, Liang XS, Derolf AR, Landgren O, Bjorkholm M, J Clin Oncol 2012 30 179 183 10.1200/JCO.2011.37.1203 22162584